Correlation Between Protagenic Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Protagenic Therapeutics and Edgewise Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Protagenic and Edgewise is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Protagenic Therapeutics is expected to under-perform the Edgewise Therapeutics. In addition to that, Protagenic Therapeutics is 4.08 times more volatile than Edgewise Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 3,357 in Edgewise Therapeutics on September 1, 2024 and sell it today you would lose (57.00) from holding Edgewise Therapeutics or give up 1.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagenic Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Protagenic Therapeutics |
| Edgewise Therapeutics |
Protagenic Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagenic Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Protagenic Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
| Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |